Novo Nordisk’s Wegovy (semaglutide), a GLP-1 weight loss drug. Photographer: George Frey/Bloomberg
© 2023 Bloomberg Finance LP
California recently passed a budget for 2025-2026 that eliminates Medicaid coverage for GLP-1 agonists for weight loss. Other states are considering similar cuts. States…